Literature DB >> 24871216

Low vancomycin MICs and fecal densities reduce the sensitivity of screening methods for vancomycin resistance in Enterococci.

Thamara M Wijesuriya1, Peta Perry2, Todd Pryce2, John Boehm2, Ian Kay2, James Flexman2, Geoffrey W Coombs3, Paul R Ingram4.   

Abstract

Active surveillance is part of a multifaceted approach used to prevent the spread of vancomycin-resistant enterococci (VRE). The impact of fecal density, the vancomycin MIC of the isolate, and the vancomycin concentration in liquid medium on test performance are uncertain. Using fecal specimens spiked with a collection of 18 VRE (predominantly vanB) with a wide vancomycin MIC range, we compared the performances of commercial chromogenic agars (CHROMagar VRE, chromID VRE, Brilliance VRE, and VRE Select) and 1 liquid medium (Enterococcosel enrichment broth) for VRE detection. The specificity of solid media was excellent; however, the sensitivity at 48 h varied from 78 to 94%. Screening using liquid medium was less sensitive than screening with solid media, particularly as the vancomycin content increased. Sensitivity declined (i) as the fecal VRE density decreased, (ii) when the media were assessed at 24 h (versus 48 h), and (iii) for isolates with a low vancomycin MIC (sensitivity, 25 to 75% versus 100% for isolates with vancomycin MIC of <16 mg/liter versus >32 mg/liter on solid medium using 10(6) CFU/ml of feces). Depending on local epidemiology and in particular VRE vancomycin MICs, the sensitivity of culture-based methods for VRE screening of stool or rectal specimens may be suboptimal, potentially facilitating secondary transmission.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24871216      PMCID: PMC4136124          DOI: 10.1128/JCM.00021-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 2.  Selective isolation of vancomycin-resistant enterococci.

Authors:  R R Nelson
Journal:  J Hosp Infect       Date:  1998-05       Impact factor: 3.926

3.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

4.  A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.

Authors:  Paul D R Johnson; Susan A Ballard; Elizabeth A Grabsch; Timothy P Stinear; Torsten Seemann; Heather L Young; M Lindsay Grayson; Benjamin P Howden
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

5.  Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates.

Authors:  Nathan A Ledeboer; Kingshuk Das; Michael Eveland; Céline Roger-Dalbert; Sandrine Mailler; Sonia Chatellier; William Michael Dunne
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

6.  Emergence and epidemiology of vancomycin-resistant enterococci in Australia.

Authors:  J Bell; J Turnidge; G Coombs; F O'Brien
Journal:  Commun Dis Intell       Date:  1998-10-29

7.  Real-time PCR for the rapid detection of vanA and vanB genes.

Authors:  Silvano Palladino; Ian D Kay; Anna Maria Costa; Erica J Lambert; James P Flexman
Journal:  Diagn Microbiol Infect Dis       Date:  2003-01       Impact factor: 2.803

Review 8.  Strategies for identification of carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2012-10-26       Impact factor: 5.790

9.  Performance of the EUCAST disk diffusion method, the CLSI agar screen method, and the Vitek 2 automated antimicrobial susceptibility testing system for detection of clinical isolates of Enterococci with low- and medium-level VanB-type vancomycin resistance: a multicenter study.

Authors:  Kristin Hegstad; Christian G Giske; Bjørg Haldorsen; Erika Matuschek; Kristian Schønning; Truls M Leegaard; Gunnar Kahlmeter; Arnfinn Sundsfjord
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

10.  Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICU.

Authors:  Guido Werner; Ingo Klare; Carola Fleige; Uta Geringer; Wolfgang Witte; Heinz-Michael Just; Renate Ziegler
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-30       Impact factor: 4.887

View more
  9 in total

1.  Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening.

Authors:  K A Morris; L R Macfarlane-Smith; M H Wilcox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-16       Impact factor: 3.267

2.  Occurrence and antibacterial susceptibility pattern of bacterial pathogens isolated from diarrheal patients in Pakistan.

Authors:  Muhammad H Rasool; Abu B Siddique; Muhammad Saqalein; Muhammad J Asghar; Muhammad A Zahoor; Bilal Aslam; Humerah B Shafiq; Muhammad A Nisar
Journal:  Saudi Med J       Date:  2016-03       Impact factor: 1.484

3.  The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study.

Authors:  Cornelius Remschmidt; Michael Behnke; Axel Kola; Luis A Peña Diaz; Anna M Rohde; Petra Gastmeier; Frank Schwab
Journal:  Antimicrob Resist Infect Control       Date:  2017-09-13       Impact factor: 4.887

4.  Development of selective medium for IMP-type carbapenemase-producing Enterobacteriaceae in stool specimens.

Authors:  Norihisa Yamamoto; Ryuji Kawahara; Yukihiro Akeda; Rathina Kumar Shanmugakani; Hisao Yoshida; Hideharu Hagiya; Naohiro Hara; Isao Nishi; Satomi Yukawa; Rumiko Asada; Yumi Sasaki; Kazuhiro Maeda; Noriko Sakamoto; Shigeyuki Hamada; Kazunori Tomono
Journal:  BMC Infect Dis       Date:  2017-03-24       Impact factor: 3.090

5.  Dissemination and genetic analysis of the stealthy vanB gene clusters of Enterococcus faecium clinical isolates in Japan.

Authors:  Yusuke Hashimoto; Jun Kurushima; Takahiro Nomura; Koichi Tanimoto; Kiyoko Tamai; Hideji Yanagisawa; Komei Shirabe; Yasuyoshi Ike; Haruyoshi Tomita
Journal:  BMC Microbiol       Date:  2018-12-13       Impact factor: 3.605

6.  Comparison of VITEK® 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.

Authors:  Ingo Klare; Jennifer K Bender; Carola Fleige; Nancy Kriebel; Axel Hamprecht; Sören Gatermann; Guido Werner
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

7.  Comparison of two chromogenic media for the detection of vancomycin-resistant enterococcal carriage by nursing home residents.

Authors:  Theodore Gouliouris; Beth Blane; Hayley J Brodrick; Kathy E Raven; Kirsty E Ambridge; Angela D Kidney; Nazreen F Hadjirin; M Estée Török; Direk Limmathurotsakul; Sharon J Peacock
Journal:  Diagn Microbiol Infect Dis       Date:  2016-05-04       Impact factor: 2.803

Review 8.  Enterococcus faecium: from microbiological insights to practical recommendations for infection control and diagnostics.

Authors:  Xuewei Zhou; Rob J L Willems; Alexander W Friedrich; John W A Rossen; Erik Bathoorn
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-10       Impact factor: 4.887

9.  Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study.

Authors:  Carlos L Correa-Martínez; Annette Jurke; Janne Schmitz; Frieder Schaumburg; Stefanie Kampmeier; Alexander Mellmann
Journal:  Microorganisms       Date:  2022-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.